Nanoliposomes mediate coenzyme q10 transport and accumulation across human intestinal caco-2 cell monolayer

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 17, 2009, Pages 7989-7996

  Shuqin, X I A ^a   Shiying, X U ^a   Zhang, Xiaoming ^a   Zhong, Fang ^a   Wang, Zhang ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Accumulation; Caco 2 cells; Coenzyme q10; Nanoliposomes; Transport

Indexed keywords

DRUG CARRIER; DRUG DERIVATIVE; LIPOSOME; NANOPARTICLE; UBIDECARENONE; UBIQUINONE;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CELL SURVIVAL; DRUG EFFECT; HUMAN; INTESTINE ABSORPTION; KINETICS; METABOLISM;

CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DRUG CARRIERS; HUMANS; INTESTINAL ABSORPTION; KINETICS; LIPOSOMES; NANOPARTICLES; UBIQUINONE;

EID: 69949171618     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf901068f     Document Type: Article

References (25)

1. Bentinger, M.; Dallner, G.; Chojnacki, T.; Swiezewska, E. Distribution and breakdown of labeled coenzyme Qi0 in rat. Free Radical Biol. Med. 2003, 34, 563-575.
2. Palamakula, A. Biopharmaceutical Classification and Development of Limonene-Based Self-Nanoemulsified Capsule Dosage Form of Coenzyme Q10. Texas Tech University: Lubbock, TX, 2004.
3. 10: formulation development and bioavailability assessment. Int. J. Pharm. 2001, 212, 233-246.
4. Enzmann, F.; Lachmann, B. Transdermal, Oral and Intravenous Preparations of 2,3-Dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone. U.S. Patent 20020155151, Oct 24, 2002.
5. (5) Sulkowski, W. W.; Pentak, D.; Nowak, K.; Sulkowska, A. The influence of temperature, cholesterol content and pH on liposome stability. J. Mol. Struct. 2005, 744-747,737-747. (Pubitemid 40717435)
6. Liang, X.; Mao, G.; Ng, K. Y. S. Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. J. Colloid Interface Sci. 2004, 275, 53-62.
7. Kokkona, M.; Kallinteri, P.; Fatouros, D.; Antimisiaris, S. G. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur. J. Pharm. Sci. 2000, 9, 245-252.
8. Kazunori, I.; Satoshi, O.; Kohji, N.; Kazuhiro, M.; Masawo, K.; Shinji, Y.; Mamoru, N.; Naoto, O. Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract. Int. J. Pharm. 1997, 157, 73-80.
9. (9) Li, H.; Song, J. H.; Park, J. S.; Han, K. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int. J. Pharm. 2003, 255, 11-19. (Pubitemid 36712866)
10. Song, K. H.; Chung, S. J.; Shim, C. K. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J. Controlled Release 2005, 106, 298-308.
11. (11) Degim, Z.; Unal, N.; Essiz, D.; Abbasoglu, U. The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. Life Sci. 2004, 75, 2819-2827. (Pubitemid 39349268)
12. (12) Moutardier, V.; Tosini, F.; Vlieghe, P.; Cara, L.; Delpero, J. R.; Clerc, T. Colloidal anticancer drugs bioavailabilities in oral administration models. Int. J. Pharm. 2003, 260, 23-38. (Pubitemid 36724858)
13. (13) Xia, S.; Xu, S.; Zhang, X. Optimization in the preparation of coenzyme Q10 nanoliposomes. J. Agric. Food. Chem. 2006, 54, 6358-6366. (Pubitemid 44367603)
14. Bradford, M. M. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of proteindye binding. Anal. Biochem. 1976, 72, 248-254.
15. Rege, B. D.; Kao, J. P. Y.; Polli, J. E. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 2002, 16, 251-346
16. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in human and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
17. Colinot, E. M.; Baldes, C.; Wempe, M. F.; Hyatt, J.; Navarro, L.; Edgar, K. J.; Schaefer, U. F.; Lehr, C. M. Influence of vitamin E TPGS polyethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J. Controlled Release 2006, 111, 35-40.
18. (18) Lo, Y. L. Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol. 2000, 60, 1381-1390. (Pubitemid 30734900)
19. Deshmukh, D. D.; Ravis, W. R.; Betageri, G. V. Improved delivery of cromolyn from oral proliposomal beads. Int. J. Pharm. 2008, 358, 128-136.
20. 10. Lancet 2003, 361, 1134-1135.
21. Kogan, A.; Kesselman, E.; Danino, D.; Aserin, A.; Garti, N. Viability and permeability across Caco-2 cells of CBZ solubilized in fully dilutable microemulsions. Colloids Surf, B 2008, 66, 1-12.
22. Lo, Y. L.; Liu, F. I.; Cherng, J. Y. Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines. J. Controlled Release 2001, 76, 1-10.
23. Gharat, L.; Taneja, R.; Weerapreeyakul, N.; Rege, B.; Polli, J.; Chikhale, P. J. Targeted drug delivery systems 6: intracellular bioreductive activation, uptake and transport of an anticancer drug delivery system across intestinal Caco-2 cell monolayers. Int. J. Pharm. 2001, 219, 1-10.
24. Ernster, L.; Dallner, G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta, Mol. Basis Dis. 1995, 1271, 195-204.
25. 10 supplementation decelerates senescence in SAMP1 mice. Exp. Gerontol. 2006, 41, 130-140.